表紙
市場調查報告書

核酸分離·精製的全球市場:產品,終端用戶,各地各國資料,競爭情形的分析與預測 - 2020年∼2029年

Global Nucleic Acid Isolation and Purification Market: Focus on Product, End User, Region/Country Data and Competitive Landscape - Analysis and Forecast, 2020-2029

出版商 BIS Research Inc. 商品編碼 931360
出版日期 內容資訊 英文 388 Pages
商品交期: 最快1-2個工作天內
價格
核酸分離·精製的全球市場:產品,終端用戶,各地各國資料,競爭情形的分析與預測 - 2020年∼2029年 Global Nucleic Acid Isolation and Purification Market: Focus on Product, End User, Region/Country Data and Competitive Landscape - Analysis and Forecast, 2020-2029
出版日期: 2020年03月31日內容資訊: 英文 388 Pages
簡介

全球核酸分離及精製的市場規模,預計2020年以金額為準增加到22億7,390萬美元的收益,從2020年到2029年之間5.98%的年複合成長率擴大,2029年達到38億3,530萬美元。

核酸分離及精製市場的增長主要歸因於基因測試的增加,對可靠的下一代測序(NGS)需求的增加,傳染病患病率的增加以及分子​​生物學領域研究資金的增加,全球性個人化醫療的認識和接受的增加等。但是,基因組數據的保護,自動化設備的高成本以及嚴格的監管標準是導致市場增長放緩的因素。

本報告以核酸分離及精製產品和廠商的詳細調查為焦點。同時更提供市場成長要素,阻礙因素,新產品、 競爭情形,主要廠商的市場佔有率,成為基礎的各子區隔之成長預定等資訊。

第1章 產品定義

第2章 調查範圍

第3章 調查手法

第4章 市場概要

  • 定義
    • 產品定義
    • 各產品定義
  • 核酸分離及精製自動化應用
    • 基因/質體DNA萃取
    • 無細胞DNA(cfDNA)開採
    • 病毒RNA開採
    • 無細胞RNA開採
  • 市場規模與成長的潛在性
    • 北美
    • 歐洲,中東·非洲(EMEA)
    • 亞太地區(APAC)
    • 南美

第5章 市場動態

  • 市場成長要素
    • 遺傳基因檢驗數的增加
    • 對次世代定序(NGS)需求的增加
    • 感染疾病的患病率上升
    • 微生物序列測定領域的崛起
    • 分子生物學領域的調查資金增加
    • 全球性個人化醫療的認識和接受的增加
  • 市場阻礙因素
    • 基因資料保護
    • 自動化設備的高成本
    • 嚴格的法規標準
  • 市場機會
    • 生物銀行的演進
    • 遺傳性疾病高患病率
    • 新興國家的成長

第6章 核酸分離及精製市場:產業考察

  • 主要的發展
    • 產品的銷售與強化
    • 合作與契約
    • 收購
    • 事業擴大
  • 產業趨勢
    • 高度穩定化產品的登場
    • 法規分析與多模態分析
    • 分離和精製的新標的
    • 新用途的探索
    • 其他主要趨勢

第7章 與核酸分離及精製市場:終端用戶價格分析

  • 器具的滿意度(不同品牌)
  • 器具的價格分析
  • 價格分析 - 配件與零件
  • 價格分析 - 消耗品

第8章 核酸分離及精製市場(各產品)

  • 簡介
  • 消耗品
    • 套件
    • 試劑
  • 器具

第9章 核酸分離及精製套件市場

  • 工作流程
    • 樣品分離/提取/精製
    • DNA / RNA淨化和濃縮
    • DNA及RNA的定量化
  • 分析對象
    • DNA
    • RNA

第10章 DNA分離及精製套件市場(各來源類型)

  • 無細胞
    • 各樣品
    • 各應用領域
  • 基因
    • 血液
    • 體液
    • 口含
    • 細胞/培養細胞
    • FFPE
    • 法醫學
    • 植物
    • 唾液/拭子
    • 血清/血漿
    • 組織
    • 糞便,尿,其他樣品
  • 細菌
    • 細菌
    • 菌類
    • 酵母
    • 其他
  • 質體
    • GigaPrep
    • MaxiPrep
    • MegaPrep
    • MidiPrep
    • MiniPrep
  • 病毒

第11章 RNA分離及精製套件市場(各來源類型)

  • 基因RNA
    • 血液
    • 體液
    • 細胞/培養細胞
    • FFPE
    • 植物
    • 唾液/拭子
    • 血清/血漿
    • 組織
    • 尿
    • 其他
  • 細菌RNA
    • 細菌
    • 酵母
    • 菌類
    • 其他
  • 病毒RNA
  • 無細胞RNA
    • 血清/血漿
    • 其他

第12章 核酸分離和精製的消耗品市場(各技術)

  • 二氧化矽為基礎的
  • 磁性粒子技術
  • 其他技術

第13章 核酸分離和精製的消耗品市場(各下游應用領域)

  • PCR
  • qPCR
  • NGS
  • 基因複製
  • 微陣列
  • 印跡技術
  • 其他的用途

第14章 核酸分離和精製的消耗品市場(各終端用戶),

  • 簡介
  • 學術調查機關及研究所
  • 製藥及生物科技企業
  • 受託調查機關
  • 應用實驗
  • 臨床診斷中心

第15章 核酸分離及精製消耗品市場(各地區)

  • 北美
    • 美國
    • 加拿大
  • 歐洲,中東·非洲(EMEA)
  • 南美 (LATAM)
  • 亞太地區
    • 中國
    • 日本
    • 其他APAC

第16章 核酸分離及精製設備市場

  • 簡介
  • 核酸的分離及精製設備市場(工作流程)
    • 分離/開採/精製
    • 品管/定量化
  • 核酸的分離及精製設備市場(科技)
    • 自動旋轉管柱為基礎的設備
    • 磁以微珠為基礎的設備
    • 自動液體分注儀設備
  • 核酸的分離及精製設備市場(容許量)
    • 低容量設備
    • 中容量設備
    • 高容量設備
  • 品管/定量化設備(各技術)
    • 分光光度計
    • 熒光計
    • 其他
  • 核酸的分離及精製設備市場(各終端用戶)
    • 學術調查機關
    • 製藥及生物科技企業
    • 臨床診斷中心
    • 應用實驗(生物銀行,法醫學及獸醫學研究所)
    • 受託調查機關
  • 核酸的分離及精製設備市場(各地區)
    • 北美
    • 歐洲,中東·非洲
    • 亞太地區
    • 南美

第17章 核酸分離及精製市場競爭情形

  • 市場佔有率分析(地區及世界)
    • 世界
    • 北美
    • 歐洲·中東·非洲地區
  • 各終端用戶的成長佔有率矩陣
  • 各地區的成長佔有率矩陣
  • 各產品的成長佔有率矩陣

第18章 策略性推薦事項

  • 重要的要點
  • 差距分析
  • 事業擴大的機會製圖
    • 各產品
    • 各地區
  • 投資機會
  • SWOT分析
  • 核酸分離及精製市場成功的策略

第19章 企業簡介

  • 概況
  • Agilent Technologies,Inc.
  • Analytik Jena AG
  • Bio-Rad Laboratories, Inc.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • General Electric Company(GE)
  • Illumina, Inc.
  • Merck KGaA
  • Meridian Bioscience,Inc.
  • Macherey-Nagel GmbH&Co KG
  • New England Biolabs, Inc
  • Norgen Biotek Corp.
  • Omega Bio-Tek
  • Orasure Technologies,Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Sage Science, Inc.
  • Tecan Group
  • ThermoFisher Scientific Inc.
  • Zymo Research

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BH175A

Global Nucleic Acid Isolation and Purification Market to Reach $3,835.2 Million by 2029

The nucleic acid isolation and purification industry analysis by BIS Research projects the market to grow at a significant CAGR of 5.98% during the forecast period, 2020-2029. The nucleic acid isolation and purification market generated $2,273.9 million revenue in 2020, in terms of value. The nucleic acid isolation and purification market growth has been primarily attributed to the major drivers in this market, such as growing number of genetic tests, increasing demand for reliable next-generation sequencing (NGS) results, rise in the prevalence of infectious diseases, increasing research funding in the field of molecular biology, and increase in awareness and acceptance of personalized medicine on a global level. However, genomic data protection, high cost of automated instruments, and rigid regulatory standards are some of the factors expected to retrain the market growth.

Expert Quote

"As molecular diagnostic testing moves into the clinical laboratory environment, products used to collect and process samples will need to be standardized"

Scope of the Market Intelligence on Nucleic Acid Isolation and Purification Market

The nucleic acid isolation and purification research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers. In addition, the study also includes exhaustive information on the drivers, restraints opportunities, perception of the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global nucleic acid isolation and purification market.

Market Segmentation

The nucleic acid isolation and purification market (on the basis of product type) is segmented into instruments and consumables (kits and reagents).

The kits segment (on the basis of technology) has been classified into magnetic particle technology, silica technology, and other technologies. The other technologies have been broadly bifurcated into anion-exchange technology, lysis, precipitation-based chemistries, organic extraction, fluorescence, and other kits technologies.

Further, the instruments (on the basis of technology) has been classified into automated spin-column based and bead-based. The bead-based technology has been further bifurcated into magnetic bead-based and automated liquid handling.

The nucleic acid isolation and purification market (on the basis of applications) is segmented into PCR, qPCR, NGS, cloning, microarray, blotting techniques, and other applications.

The nucleic acid isolation and purification market (on the basis of end-user) is segmented into academic research institutes, pharmaceutical and biotechnology companies, applied testing, biobanks, contract research organizations, hospital research laboratories, and clinical diagnostic centers.

The nucleic acid isolation and purification market (on the basis of region) is segmented into North America, EMEA, Asia-Pacific, and Latin America.

Key Companies in the Nucleic Acid Isolation and Purification Market

The key manufacturers who have been contributing significantly to the nucleic acid isolation and purification market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F.Hoffmann-La Roche AG, Illumina, Inc., General Electric Company (GE), New England Biolabs, Inc., Promega Corporation, Merck KGaA, Takara Bio Inc., QIAGEN N.N., Thermo Fisher Scientific Inc., and Promega Corporation, among others.

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Research Scope

  • 2.1 Scope of the Study
  • 2.2 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Global Nucleic Acid Isolation and Purification Market: Research Methodology
  • 3.2 Primary Data Sources
  • 3.3 Secondary Data Sources
  • 3.4 Market Estimation Model

4 Market Overview

  • 4.1 Definitions
    • 4.1.1 Product Definition
    • 4.1.2 Definition by Products
      • 4.1.2.1 Instruments
      • 4.1.2.2 Column-Based Instruments
      • 4.1.2.3 Bead-Based Instruments
      • 4.1.2.4 Low-Throughput Instruments
      • 4.1.2.5 Medium-Throughput Instruments
      • 4.1.2.6 High-Throughput Instruments
      • 4.1.2.7 Kits
      • 4.1.2.8 Reagents
  • 4.2 Nucleic Acid Isolation and Purification Automation Applications
    • 4.2.1 Genomic/Plasmid DNA Extraction
    • 4.2.2 Cell-Free DNA (cfDNA) Extraction
    • 4.2.3 Viral RNA Extraction
    • 4.2.4 Cell-Free RNA Extraction
  • 4.3 Market Size and Growth Potential, $Million, 2019-2029
    • 4.3.1 North America
    • 4.3.2 Europe, Middle East & Africa (EMEA)
    • 4.3.3 Asia-Pacific (APAC)
    • 4.3.4 Latin America

5 Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Number of Genetic Tests
    • 5.1.2 Increasing Demand for Reliable Next-Generation Sequencing (NGS) Results
    • 5.1.3 Rise in the Prevalence of Infectious Disease
    • 5.1.4 Rise in the Field of Microbial Sequencing
    • 5.1.5 Increasing Research Funding in the Field of Molecular Biology
    • 5.1.6 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
  • 5.2 Market Restraints
    • 5.2.1 Genomic Data Protection
    • 5.2.2 High Cost of Automated Instruments
    • 5.2.3 Rigid Regulatory Standards
  • 5.3 Market Opportunities
    • 5.3.1 Evolution of Biobanking in Healthcare
    • 5.3.2 Capitalizing on the High Prevalence of Genetic Disorders
    • 5.3.3 Growth in Emerging Nations

6 Nucleic Acid Isolation and Purification Market: Industry Insights

  • 6.1 Key Developments
    • 6.1.1 Product Launches and Enhancements
    • 6.1.2 Collaborations and Agreements
    • 6.1.3 Acquisitions
    • 6.1.4 Business Expansions
  • 6.2 Industry Trends
    • 6.2.1 Emergence of Advanced Stabilization Products
    • 6.2.2 Regulated vs. Multimodal Analysis
    • 6.2.3 Novel Targets for Isolation and Purification
    • 6.2.4 Exploring New Applications
    • 6.2.5 Other Key Trends

7 Nucleic Acid Isolation and Purification Market: End User and Pricing Analysis

  • 7.1 Satisfaction Level of Different Instruments (by Brand)
  • 7.2 Pricing Analysis of Preferred Instruments
  • 7.3 Pricing Analysis - Accessories and Components
  • 7.4 Pricing Analysis - Consumables

8 Nucleic Acid Isolation and Purification Market (by Product), $Million, 2019-2029

  • 8.1 Introduction
  • 8.2 Consumables
    • 8.2.1 Kits
    • 8.2.2 Reagents
  • 8.3 Instruments

9 Nucleic Acid Isolation and Purification Kits Market, $Million, 2019-2029

  • 9.1 By Workflow
    • 9.1.1 Sample Isolation/Extraction/Purification
    • 9.1.2 DNA/RNA Clean-Up and Concentration
    • 9.1.3 DNA and RNA Quantification
  • 9.2 By Analyte
    • 9.2.1 DNA
    • 9.2.2 RNA

10 DNA Isolation and Purification Kits Market, (by Source Type) $Million, 2019-2029

  • 10.1 Cell-Free
    • 10.1.1 By Sample
      • 10.1.1.1 Blood
      • 10.1.1.2 Serum/Plasma
      • 10.1.1.3 Other Sources
    • 10.1.2 By Application
      • 10.1.2.1 Parental and Hereditary Testing
      • 10.1.2.2 Tumor Testing
      • 10.1.2.3 Transplantation
  • 10.2 Genomic
    • 10.2.1 Blood
    • 10.2.2 Body Fluids
    • 10.2.3 Buccal
    • 10.2.4 Cell/Cultured Cell
    • 10.2.5 FFPE
    • 10.2.6 Forensic
    • 10.2.7 Plant
    • 10.2.8 Saliva/Swab
    • 10.2.9 Serum/Plasma
    • 10.2.10 Tissue
    • 10.2.11 Stool, Urine, and Other Samples
  • 10.3 Microbe
    • 10.3.1 Bacterial
    • 10.3.2 Fungus
    • 10.3.3 Yeast
    • 10.3.4 Other Sources
  • 10.4 Plasmid
    • 10.4.1 GigaPrep
    • 10.4.2 MaxiPrep
    • 10.4.3 MegaPrep
    • 10.4.4 MidiPrep
    • 10.4.5 MiniPrep
  • 10.5 Viral

11 RNA Isolation and Purification Kits Market (by Source Type) $Million, 2019-2029

  • 11.1 Genomic RNA
    • 11.1.1 Blood
    • 11.1.2 Body Fluids
    • 11.1.3 Cell/Cultured Cell
    • 11.1.4 FFPE
    • 11.1.5 Plant
    • 11.1.6 Saliva/Swab
    • 11.1.7 Serum/Plasma
    • 11.1.8 Tissue
    • 11.1.9 Urine
    • 11.1.10 Others
  • 11.2 Microbial RNA
    • 11.2.1 Bacteria
    • 11.2.2 Yeast
    • 11.2.3 Fungus
    • 11.2.4 Others
  • 11.3 Viral RNA
  • 11.4 Cell-Free RNA
    • 11.4.1 Serum/Plasma
    • 11.4.2 Others

12 Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2019-2029

  • 12.1 Silica-Based
  • 12.2 Magnetic Particle Technology
  • 12.3 Other Technologies

13 Nucleic Acid Isolation and Purification Consumables Market (by Downstream Applications), $Million, 2019-2029

  • 13.1 PCR
  • 13.2 qPCR
  • 13.3 NGS
  • 13.4 Cloning
  • 13.5 Microarray
  • 13.6 Blotting Techniques
  • 13.7 Other Applications

14 Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2019-2029

  • 14.1 Introduction
  • 14.2 Academic Research Institutes and Laboratories
  • 14.3 Pharmaceutical and Biotechnology Companies
  • 14.4 Contract Research Organizations
  • 14.5 Applied Testing
  • 14.6 Clinical Diagnostic Centers

15 Nucleic Acid Isolation and Purification Consumables Market (by Region)

  • 15.1 North America
    • 15.1.1 U.S.
    • 15.1.2 Canada
  • 15.2 Europe, Middle East & Africa (EMEA)
  • 15.3 Latin America (LATAM)
  • 15.4 Asia-Pacific
    • 15.4.1 China
    • 15.4.2 Japan
    • 15.4.3 Rest-of-APAC

16 Nucleic Acid Isolation and Purification Instrument Market

  • 16.1 Introduction
  • 16.2 Nucleic Acid Isolation and Purification Instrument Market (by Workflow)
    • 16.2.1 Isolation/Extraction/Purification
    • 16.2.2 Quality Control/Quantification
  • 16.3 Nucleic Acid Isolation and Purification Instrument Market (by Technology)
    • 16.3.1 Automated Spin Column-Based Instruments
    • 16.3.2 Magnetic Bead-based Instruments
    • 16.3.3 Automated Liquid Handling Instruments
  • 16.4 Nucleic Acid Isolation and Purification Instrument Market (by Throughput)
    • 16.4.1 Low Throughput Instruments
    • 16.4.2 Medium Throughput Instruments
    • 16.4.3 High Throughput Instruments
  • 16.5 Quality Control/Quantification Instruments (by Technology)
    • 16.5.1 Spectrophotometer
    • 16.5.2 Fluorometers
    • 16.5.3 Others
  • 16.6 Nucleic Acid Isolation and Purification Instrument Market (by End User)
    • 16.6.1 Academic Research Institutes
    • 16.6.2 Pharmaceutical and Biotechnology Companies
    • 16.6.3 Clinical Diagnostic Centers
    • 16.6.4 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
    • 16.6.5 Contract Research Organizations
  • 16.7 Nucleic Acid Isolation and Purification Instrument Market (by Region)
    • 16.7.1 North America
      • 16.7.1.1 U.S.
      • 16.7.1.2 Canada
    • 16.7.2 Europe, Middle East and Africa
    • 16.7.3 Asia-Pacific
      • 16.7.3.1 China
      • 16.7.3.2 Japan
      • 16.7.3.3 Rest-of-APAC
    • 16.7.4 Latin America

17 Nucleic Acid Isolation and Purification Market Competitive Landscape

  • 17.1 Market Share Analysis (Regional and Global)
    • 17.1.1 Global
    • 17.1.2 North America
    • 17.1.3 EMEA
  • 17.2 Growth Share Matrix by End User
  • 17.3 Growth Share Matrix by Region
  • 17.4 Growth Share Matrix by Products

18 Strategic Recommendations

  • 18.1 Key Takeaways
  • 18.2 Gap Analysis
  • 18.3 Business Expansion Opportunity Mapping
    • 18.3.1 By Product
    • 18.3.2 By Region
  • 18.4 Investment Opportunities
  • 18.5 SWOT Analysis
  • 18.6 Propitious Strategies to Succeed in Nucleic Acid Isolation and Purification Market

19 Company Profiles

  • 19.1 Overview
  • 19.2 Agilent Technologies, Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Role of Agilent Technologies, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 19.2.3 Financials
    • 19.2.4 Key Insights About Financial Health of the Company
    • 19.2.5 SWOT Analysis
  • 19.3 Analytik Jena AG
    • 19.3.1 Company Overview
    • 19.3.2 Role of Analytik Jena AG in the Global Nucleic Acid Isolation and Purification Market
    • 19.3.3 SWOT Analysis
  • 19.4 Bio-Rad Laboratories, Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 19.4.3 Financials
    • 19.4.4 Key Insights About Financial Health of the Company
    • 19.4.5 SWOT Analysis
  • 19.5 Exact Sciences Corporation
    • 19.5.1 Company Overview
    • 19.5.2 Role of Exact Sciences Corporation in the Global Nucleic Acid Isolation and Purification Market
    • 19.5.3 Financials
    • 19.5.4 Key Insights about Financial Health of the Company
    • 19.5.5 SWOT Analysis
  • 19.6 F. Hoffmann-La Roche AG
    • 19.6.1 Company Overview
    • 19.6.2 Role of F. Hoffmann-La Roche AG in the Global Nucleic Acid Isolation and Purification Market
    • 19.6.3 Financials
    • 19.6.4 Key Insights About Financial Health of the Company
    • 19.6.5 SWOT Analysis
  • 19.7 General Electric Company (GE)
    • 19.7.1 Company Overview
    • 19.7.2 Role of GE in the Global Nucleic Acid Isolation and Purification Market
    • 19.7.3 Financials
    • 19.7.4 Key Insights about Financial Health of the Company
    • 19.7.5 SWOT Analysis
  • 19.8 Illumina, Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Role of Illumina, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 19.8.3 Financials
    • 19.8.4 Key Insights About Financial Health of the Company
    • 19.8.5 SWOT Analysis
  • 19.9 Merck KGaA
    • 19.9.1 Company Overview
    • 19.9.2 Role of Merck KGaA in the Global Nucleic Acid Isolation and Purification Market
    • 19.9.3 Financials
    • 19.9.4 Key Insights About Financial Health of the Company
    • 19.9.5 SWOT Analysis
  • 19.10 Meridian Bioscience, Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Role of Meridian Bioscience in the Global Nucleic Acid Isolation and Purification Market
    • 19.10.3 Financials
    • 19.10.4 Key Insights about Financial Health of the Company
    • 19.10.5 SWOT Analysis
  • 19.11 Macherey-Nagel GmbH & Co KG
    • 19.11.1 Company Overview
    • 19.11.2 Role of Macherey-Nagel GmbH & Co KG in the Global Nucleic Acid Isolation and Purification Market
    • 19.11.3 SWOT Analysis
  • 19.12 New England Biolabs, Inc
    • 19.12.1 Company Overview
    • 19.12.2 Role of New England Biolabs, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 19.12.3 SWOT Analysis
  • 19.13 Norgen Biotek Corp.
    • 19.13.1 Company Overview
    • 19.13.2 Role of Norgen Biotek Corp. in the Global Nucleic Acid Isolation and Purification Market
    • 19.13.3 SWOT Analysis
  • 19.14 Omega Bio-Tek
    • 19.14.1 Company Overview
    • 19.14.2 Role of Omega Bio-Tek in the Global Nucleic Acid Isolation and Purification Market
    • 19.14.3 SWOT Analysis
  • 19.15 Orasure Technologies, Inc.
    • 19.15.1 Company Overview
    • 19.15.2 Role of Orasure Technologies in the Global Nucleic Acid Isolation and Purification Market
    • 19.15.3 Financials
    • 19.15.4 Key Insights about Financial Health of the Company
    • 19.15.5 SWOT Analysis
  • 19.16 PerkinElmer, Inc.
    • 19.16.1 Company Overview
    • 19.16.2 Role of PerkinElmer, Inc. in the Nucleic Acid Isolation and Purification Market
    • 19.16.3 Financials
    • 19.16.4 SWOT Analysis
  • 19.17 Promega Corporation
    • 19.17.1 Company Overview
    • 19.17.2 Role of Promega Corporation in the Global Nucleic Acid Isolation and Purification Market
    • 19.17.3 SWOT Analysis
  • 19.18 QIAGEN N.V.
    • 19.18.1 Company Overview
    • 19.18.2 Role of QIAGEN N.V. plc in the Global Nucleic Acid Isolation and Purification Market
    • 19.18.3 Financials
    • 19.18.4 Key Insights About Financial Health of the Company
    • 19.18.5 SWOT Analysis
  • 19.19 Sage Science, Inc.
    • 19.19.1 Company Overview
    • 19.19.2 Role of Sage Science, Inc. in the Global Nucleic Acid Isolation and Purification Market
    • 19.19.3 SWOT Analysis
  • 19.20 Tecan Group
    • 19.20.1 Company Overview
    • 19.20.2 Role of Tecan Group in the Global Nucleic Acid Isolation and Purification Market
    • 19.20.3 Financials
    • 19.20.4 Key Insights about Financial Health of the Company
    • 19.20.5 SWOT Analysis
  • 19.21 ThermoFisher Scientific Inc.
    • 19.21.1 Company Overview
    • 19.21.2 Role of Thermo Fisher Scientific in the Global Nucleic Acid Isolation and Purification Market
    • 19.21.3 Financials
    • 19.21.4 Key Insights About Financial Health of the Company
    • 19.21.5 SWOT Analysis
  • 19.22 Zymo Research
    • 19.22.1 Company Overview
    • 19.22.2 Role of Zymo Research in the Global Nucleic Acid Isolation and Purification Market
    • 19.22.3 SWOT Analysis

List of Tables

  • Table 5.1: Other Key Research Funding for Nucleic Acid Extraction
  • Table 6.1: Commercially Available CTC Isolation Technologies
  • Table 6.2: Key Market Players Offering UltraPure Extraction Kits
  • Table 7.1: Key Automated DNA Extraction Systems Price and Material Cost per Sample
  • Table 7.2: Pricing of Market Available Consumables
  • Table 12.1: Other Technologies Consumables Market, $Million, 2019-2029
  • Table 14.1: Academic Research Institutes and Laboratories Consumables Market (by Analyte), $Million, 2019-2029
  • Table 14.2: Pharmaceutical and Biotechnology Companies Consumables Market (by Analyte), $Million, 2019-2029
  • Table 14.3: Contract Research Organizations Consumables Market (by Analyte), $Million, 2019-2029
  • Table 14.4: Applied Testing Consumables Market, (by Analyte) $Million, 2019-2029
  • Table 14.5: Contract Research Organizations Consumables Market (by Analyte), $Million, 2019-2029
  • Table 15.1: Global Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2019-2029
  • Table 15.2: Global DNA Isolation and Purification Kits Market (by Region), $Million, 2019-2029
  • Table 15.3: Global RNA Isolation and Purification Kits Market (by Region), $Million, 2019-2029
  • Table 15.4: Global Nucleic Acid Isolation and Purification Reagents Market (by Region), $Million, 2019-2029
  • Table 15.5: North America Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2019-2029
  • Table 15.6: North America DNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
  • Table 15.7: North America RNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
  • Table 15.8: EMEA Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2019-2029
  • Table 15.9: EMEA Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2019-2029
  • Table 15.10: EMEA DNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
  • Table 15.11: EMEA RNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
  • Table 15.12: LATAM Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2019-2029
  • Table 15.13: LATAM Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2019-2029
  • Table 15.14: LATAM DNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
  • Table 15.15: LATAM RNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
  • Table 15.16: APAC Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2019-2029
  • Table 15.17: APAC Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2019-2029
  • Table 15.18: APAC DNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
  • Table 15.19: APAC RNA Isolation and Purification Kits Market (by Source), $Million, 2019-2029
  • Table 16.1: Key Isolation/Extraction/Purification Systems for Nucleic Acids
  • Table 16.2: Key Quality Control/Quantification Systems for Nucleic Acids
  • Table 16.3: Key Column-Based Systems for Nucleic Acid Extraction
  • Table 16.4: Key Magnetic Bead-Based Systems for Nucleic Acid Extraction
  • Table 16.5: Key Low Throughput Systems for Nucleic Acid Extraction
  • Table 16.6: Key Medium Throughput Systems for Nucleic Acid Extraction
  • Table 16.7: Key High Throughput Systems for Nucleic Acid Extraction
  • Table 16.8: Key Spectrophotometer Systems for Quality Control/Quantification
  • Table 16.9: Key Fluorometers Systems for Quality Control/Quantification
  • Table 16.10: Key Other Systems for Quality Control/Quantification
  • Table 16.11: Collaborations in Genetics and Genomics Research in Africa, by Funder
  • Table 18.1: Major Issues in Research Laboratories in the Asia-Pacific Region
  • Table 18.2: Funding Scenario in the Competitive Genomic Landscape

List of Figures

  • Figure 1: Cumulative Number of Tested Conditions and Associated Genes for Genetic Testing, 2012-2019
  • Figure 2: Impact Analysis on the Global Nucleic Acid Isolation and Purification Market
  • Figure 3: Nucleic Acid Isolation and Purification Market, (by Product), $Million, 2019 vs. 2029
  • Figure 4: Nucleic Acid Isolation and Purification Consumables Market, (by Type), $Million, 2019 vs. 2029
  • Figure 5: Nucleic Acid Isolation and Purification Consumables Market, (by Technology), $Million, 2018 vs. 2029
  • Figure 6: Nucleic Acid Isolation and Purification Consumables Market, (by End User), $Million, 2019 vs. 2029
  • Figure 7: Global Nucleic Acid Isolation and Purification Consumables Market Snapshot, (by Region)
  • Figure 8: Nucleic Acid Isolation and Purification Instrument Market, (by Technology), $Million, 2019 vs. 2029
  • Figure 9: Nucleic Acid Isolation and Purification Instrument Market, (by Throughput), $Million, 2019 vs. 2029
  • Figure 10: Global Nucleic Acid Isolation and Purification Instrument Market Snapshot, (by Region)
  • Figure 2.1: Global Nucleic Acid Isolation and Purification Market Segmentation
  • Figure 3.1: Global Nucleic Acid Isolation and Purification Market Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 3.5: Forecast Methodology
  • Figure 4.1: North America Nucleic Acid Isolation and Purification Addressable Market, 2019 and 2029
  • Figure 4.2: EMEA Nucleic Acid Isolation and Purification Addressable Market, 2019-2029
  • Figure 4.3: Asia-Pacific Nucleic Acid Isolation and Purification Addressable Market, 2019-2029
  • Figure 4.4: Latin America Nucleic Acid Isolation and Purification Addressable Market, 2019-2029
  • Figure 5.1: Market Dynamics of Global Nucleic Acid Isolation and Purification Market
  • Figure 5.2: Key Genetic Disorder Prevalence in the U.S., 2012-2017
  • Figure 6.1: Share of Key Developments and Strategies
  • Figure 7.1: Nucleic Acid Isolation and Purification Customer Preference (by Major Brand), N=27
  • Figure 7.2: Nucleic Acid Isolation and Purification Customer Satisfaction Level (5 Being the Highest) (by Brand) (N=27)
  • Figure 8.1: Nucleic Acid Isolation and Purification Market (by Product), $Million, 2020 and 2029
  • Figure 8.2: Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 8.3: Nucleic Acid Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 8.4: Nucleic Acid Isolation and Purification Reagents Market, $Million, 2019-2029
  • Figure 8.5: Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 9.1: Nucleic Acid Isolation and Purification Kits Market (by Workflow), $Million, 2020 and 2029
  • Figure 9.2: Sample Isolation/Extraction/Purification Kits Market, $Million, 2019-2029
  • Figure 9.3: DNA/RNA Clean-Up and concentration Kits Market, $Million, 2019-2029
  • Figure 9.4: DNA and RNA Quantification Kits Market, $Million, 2019-2029
  • Figure 9.5: Nucleic Acid Isolation and Purification Kits Market (by Analyte), $Million, 2020 and 2029
  • Figure 9.6: DNA Kits Market, $Million, 2019-2029
  • Figure 9.7: Market Share for DNA Kits Market, $Million, 2018
  • Figure 9.8: RNA Kits Market, $Million, 2019-2029
  • Figure 9.9: Market Share for RNA Kits Market, $Million, 2018
  • Figure 10.1: DNA Isolation and Purification Kits Market (by Source Type), $Million, 2020 and 2029
  • Figure 10.2: Cell-Free DNA Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.3: Market Share for Cell-Free DNA Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.4: Cell-Free DNA Isolation and Purification Kits Market for Blood, $Million, 2019-2029
  • Figure 10.5: Cell-Free DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2019-2029
  • Figure 10.6: Cell-Free DNA Isolation and Purification Kits Market for Other Sources, $Million, 2019-2029
  • Figure 10.7: Cell-Free DNA Isolation and Purification Kits Market for Prenatal and Hereditary Testing, $Million, 2019-2029
  • Figure 10.8: Cell-Free DNA Isolation and Purification Kits Market for Tumor Testing, $Million, 2019-2029
  • Figure 10.9: Cell-Free DNA Isolation and Purification Kits Market for Transplantation, $Million, 2019-2029
  • Figure 10.10: Genomic DNA Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.11: Market Share for Genomic DNA Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.12: Genomic DNA Isolation and Purification Kits Market for Blood, $Million, 2019-2029
  • Figure 10.13: Market Share for Genomic DNA Isolation and Purification Market for Blood, $Million, 2018
  • Figure 10.14: Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, 2019-2029
  • Figure 10.15: Market Share for Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, (2018)
  • Figure 10.16: Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2019-2029
  • Figure 10.17: Market Share for Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2018
  • Figure 10.18: Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2019-2029
  • Figure 10.19: Market Share for Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2018
  • Figure 10.20: Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2019-2029
  • Figure 10.21: Market Share for Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2018
  • Figure 10.22: Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2019-2029
  • Figure 10.23: Market Share for Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2018
  • Figure 10.24: Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2019-2029
  • Figure 10.25: Market Share for Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2018
  • Figure 10.26: Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2019-2029
  • Figure 10.27: Market Share for Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2018
  • Figure 10.28: Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2019-2029
  • Figure 10.29: Market Share for Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2018
  • Figure 10.30: Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2019-2029
  • Figure 10.31: Market Share for Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2018
  • Figure 10.32: Genomic DNA Isolation and Purification Kits Market for Combined Segment, $Million, 2019-2029
  • Figure 10.33: Market Share for Genomic DNA Isolation and Purification Kits Market for Combined Segment, $Million, 2018
  • Figure 10.34: Microbe DNA Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.35: Market Share for Microbe DNA Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.36: Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2019-2029
  • Figure 10.37: Market Share for Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2018
  • Figure 10.38: Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2019-2029
  • Figure 10.39: Market Share for Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2018
  • Figure 10.40: Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2019-2029
  • Figure 10.41: Market Share for Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2018
  • Figure 10.42: Microbial DNA Isolation and Purification Kits Market for Other Sources, $Million, 2019-2029
  • Figure 10.43: Plasmid DNA Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.44: Market Share for Plasmid DNA Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.45: Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.46: Market Share for Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.47: Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.48: Market Share for Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.49: Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.50: Market Share for Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.51: Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.52: Market Share for Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.53: Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.54: Market Share for Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2018
  • Figure 10.55: Viral DNA Isolation and Purification Kits Market, $Million, 2019-2029
  • Figure 10.56: Market Share for Viral DNA Isolation and Purification Kits Market, $Million, 2018
  • Figure 11.1: RNA Isolation and Purification Kits Market, $Million, 2020 and 2029
  • Figure 11.2: Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.3: Genomic RNA Kits Market Share, 2018
  • Figure 11.4: Genomic RNA Kits for Blood Market, $Million, 2019-2029
  • Figure 11.5: Genomic RNA Extraction Kits from Blood, Market Share, 2018
  • Figure 11.6: Body Fluids Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.7: Cell/Cultured Cell Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.8: Cell/Cultured Cell Genomic RNA Extraction Kits, Market Share, 2018
  • Figure 11.9: FFPE Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.10: FFPE Genomic RNA Extraction Kits, Market Share, 2018
  • Figure 11.11: Plant Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.12: Plant Genomic RNA Extraction Kits, Market Share, 2018
  • Figure 11.13: Saliva/Swab Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.14: Serum/Plasma Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.15: Serum/Plasma Genomic RNA Extraction Kits, Market Share, 2018
  • Figure 11.16: Tissue Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.17: Tissue Genomic RNA Extraction Kits, Market Share, 2018
  • Figure 11.18: Urine Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.19: Other Genomic RNA Kits Market, $Million, 2019-2029
  • Figure 11.20: Microbial RNA Kits Market, $Million, 2019-2029
  • Figure 11.21: Microbial RNA Kits Market Share, 2018
  • Figure 11.22: Bacterial RNA Kits Market, $Million, 2019-2029
  • Figure 11.23: Bacterial RNA Kits Market Share, 2018
  • Figure 11.24: Yeast RNA Kits Market, $Million, 2019-2029
  • Figure 11.25: Yeast RNA Kits Market Share, 2018
  • Figure 11.26: Fungus RNA Kits Market, $Million, 2019-2029
  • Figure 11.27: Fungal RNA Kits Market Share, 2018
  • Figure 11.28: Other Microbial RNA Kits Market, $Million, 2019-2029
  • Figure 11.29: Viral RNA Kits Market, $Million, 2019-2029
  • Figure 11.30: Viral RNA Kits Market Share, 2018
  • Figure 11.31: Cell-Free RNA Kits Market, $Million, 2019-2029
  • Figure 11.32: cell-free RNA Kits Market Share, 2018
  • Figure 11.33: Serum/Plasma Cell-Free RNA Kits Market, $Million, 2019-2029
  • Figure 11.34: Other Cell-Free RNA Kits Market, $Million, 2019-2029
  • Figure 12.1: Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2020 and 2029
  • Figure 12.2: Silica-Based Consumables Market, $Million, 2019-2029
  • Figure 12.3: Magnetic Particle-based Consumables Market, $Million, 2019-2029
  • Figure 13.1: Nucleic Acid Isolation and Purification Consumables Market (by Technological Downstream Applications), $Million, 2020 and 2029
  • Figure 13.2: PCR Market, $Million, 2019-2029
  • Figure 13.3: qPCR Market, $Million, 2019-2029
  • Figure 13.4: NGS Market, $Million, 2019-2029
  • Figure 13.5: Cloning Market, $Million, 2019-2029
  • Figure 13.6: Microarray Market, $Million, 2019-2029
  • Figure 13.7: Blotting Techniques Market, $Million, 2019-2029
  • Figure 13.8: Other Applications Market, $Million, 2019-2029
  • Figure 14.1: Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2020 and 2029
  • Figure 14.2: Academic Research Institutes and Laboratories Market, $Million, 2019-2029
  • Figure 14.3: Pharmaceutical and Biotechnology Companies Market, $Million, 2019-2029
  • Figure 14.4: Contract Research Organizations Market, $Million, 2019-2029
  • Figure 14.5: Applied Testing Market, $Million, 2019-2029
  • Figure 14.6: Clinical Diagnostic Center Market, $Million, 2019-2029
  • Figure 15.1: Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2020 and 2029
  • Figure 15.2: North America Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 15.3: U.S. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 15.4: Canada Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 15.5: EMEA Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 15.6: LATAM Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 15.7: APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 15.8: China Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 15.9: Japan Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 15.10: Rest-of-APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2019-2029
  • Figure 16.1: Nucleic Acid Isolation and Purification Instrument Market (by Workflow), $Million, 2019 and 2029
  • Figure 16.2: Isolation/Extraction/Purification Instrument Market, $Million, 2019-2029
  • Figure 16.3: Quality Control/Quantification Instrument Market, $Million, 2019-2029
  • Figure 16.4: Nucleic Acid Isolation and Purification Instrument Market (by Technology), $Million, 2019 and 2029
  • Figure 16.5: Automated Spin Column-Based Instrument Market, $Million, 2019-2029
  • Figure 16.6: Magnetic Bead-based Instrument Market, $Million, 2019-2029
  • Figure 16.7: Automated Liquid Handling Instruments Market, $Million, 2019-2029
  • Figure 16.8: Nucleic Acid Isolation and Purification Instrument Market (by Throughput), $Million, 2019 and 2029
  • Figure 16.9: Low Throughput Instrument Market, $Million, 2019-2029
  • Figure 16.10: Medium Throughput Instrument Market, $Million, 2019-2029
  • Figure 16.11: High Throughput Instrument Market, $Million, 2019-2029
  • Figure 16.12: Quality Control/Quantification Instruments, (by Technology), $Million, 2019 and 2029
  • Figure 16.13: Spectrophotometers Market, $Million, 2019-2029
  • Figure 16.14: Fluorometers Market, $Million, 2019-2029
  • Figure 16.15: Others Market, $Million, 2019-2029
  • Figure 16.16: Nucleic Acid Isolation and Purification Instrument Market (by End User), $Million, 2019 and 2029
  • Figure 16.17: Nucleic Acid Isolation and Purification Instrument Market for Academic Research Institutes, $Million, 2019-2029
  • Figure 16.18: Nucleic Acid Isolation and Purification Instrument Market for Pharmaceutical and Biotechnology Companies, $Million, 2019-2029
  • Figure 16.19: Nucleic Acid Isolation and Purification Instrument Market for Clinical Diagnostic Centers, $Million, 2019-2029
  • Figure 16.20: Nucleic Acid Isolation and Purification Instrument Market for Applied Testing, $Million, 2019-2029
  • Figure 16.21: Nucleic Acid Isolation and Purification Instrument Market for Contract Research Organizations, $Million, 2019-2029
  • Figure 16.22: Nucleic Acid Isolation and Purification Instrument Market (by Region), $Million, 2019 and 2029
  • Figure 16.23: North America Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 16.24: North America Nucleic Acid Isolation and Purification Instrument Market (by Country), $Million, 2019-2029
  • Figure 16.25: U.S. Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 16.26: Canada Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 16.27: EMEA Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 16.28: APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 16.29: APAC Nucleic Acid Isolation and Purification Instrument Market (by Country) $Million, 2019-2029
  • Figure 16.30: China Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 16.31: Japan Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 16.32: Rest-of-APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 16.33: LATAM Nucleic Acid Isolation and Purification Instrument Market, $Million, 2019-2029
  • Figure 17.1: Market Share Analysis for the Global Nucleic Acid Isolation and Purification Instrument Market, 2018
  • Figure 17.2: Global Nucleic Acid Isolation and Purification Kits Market Share, 2018
  • Figure 17.3: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Instrument Market, 2018
  • Figure 17.4: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Kits Market, 2018
  • Figure 17.5: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Instrument Market, 2018
  • Figure 17.6: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Kits Market, 2018
  • Figure 17.7: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by End User)
  • Figure 17.8: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Region)
  • Figure 17.9: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Product)
  • Figure 18.1: Business Expansion Opportunity Mapping (by Product)
  • Figure 18.2: Business Expansion Opportunity Mapping (by Region)
  • Figure 18.3: Nucleic Acid Isolation and Purification Market: SWOT Analysis
  • Figure 19.1: Total Number of Companies Profiles
  • Figure 19.2: Agilent Technologies, Inc.: Key Product Portfolio
  • Figure 19.3: Agilent Technologies, Inc.: Overall Financials, 2017-2019
  • Figure 19.4: Agilent Technologies, Inc.: Revenue (by Segment), 2017-2019
  • Figure 19.5: Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
  • Figure 19.6: Agilent Technologies, Inc.: R&D Expenditure, 2017-2019
  • Figure 19.7: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 19.8: Analytik Jena AG: Key Product Portfolio
  • Figure 19.9: Analytik Jena AG: SWOT Analysis
  • Figure 19.10: Bio-Rad Laboratories, Inc.: Key Product Portfolio
  • Figure 19.11: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
  • Figure 19.12: Bio-Rad Laboratories, Inc.: Sales (by Segment), $Million, 2016-2018
  • Figure 19.13: Bio-Rad Laboratories, Inc.: Sales (by Region), 2016-2018
  • Figure 19.14: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2016-2018
  • Figure 19.15: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 19.16: Exact Sciences Corporation: Key Product Portfolio
  • Figure 19.17: Exact Sciences Corporation: Overall Financials, 2017-2019
  • Figure 19.18: Exact Sciences Corporation: Revenue (by Region), 2017-2019
  • Figure 19.19: Exact Sciences Corporation: R&D Expenditure, 2017-2019
  • Figure 19.20: Exact Sciences Corporation: SWOT Analysis
  • Figure 19.21: F. Hoffmann-La Roche AG: Key Product Portfolio
  • Figure 19.22: F. Hoffmann-La Roche AG: Overall Financials, 2016-2018
  • Figure 19.23: F. Hoffmann-La Roche AG: Revenue (by Segment), $Million, 2016-2018
  • Figure 19.24: F. Hoffmann-La Roche AG: Revenue (by Region), 2016-2018
  • Figure 19.25: F. Hoffmann-La Roche AG: R&D Expenditure, 2016-2018
  • Figure 19.26: F. Hoffmann-La Roche AG: SWOT Analysis
  • Figure 19.27: GE: Key Product Portfolio
  • Figure 19.28: General Electric Company: Overall Financials, 2016-2018
  • Figure 19.29: General Electric Company: Revenue (by Segment), 2016-2018
  • Figure 19.30: General Electric Company: Revenue Split for Healthcare, 2016-2018
  • Figure 19.31: General Electric: Healthcare Revenue (by Region), 2016-2018
  • Figure 19.32: General Electric Company: R&D Expenditure, 2016-2018
  • Figure 19.33: General Electric Company: SWOT Analysis
  • Figure 19.34: Illumina, Inc.: Key Product Portfolio
  • Figure 19.35: Illumina, Inc.: Overall Financials, 2016-2018
  • Figure 19.36: Illumina, Inc.: Revenue (by Segment), $Million, 2016-2018
  • Figure 19.37: Illumina, Inc.: Revenue (by Region), 2016-2018
  • Figure 19.38: Illumina, Inc.: R&D Expenditure, 2016-2018
  • Figure 19.39: Illumina, Inc.: SWOT Analysis
  • Figure 19.40: Merck KGaA: Key Product Offerings
  • Figure 19.41: Merck KGaA: Overall Financials, 2016-2018
  • Figure 19.42: Merck KGaA: Revenue (by Segment), $Million, 2016-2018
  • Figure 19.43: Merck KGaA: Revenue (by Region), 2016-2018
  • Figure 19.44: Merck KGaA: R&D Expenditure, 2016-2018
  • Figure 19.45: Merck KGaA: SWOT Analysis
  • Figure 19.46: Meridian Bioscience: Key Product Portfolio
  • Figure 19.47: Meridian Bioscience: Overall Financials, 2017-2019
  • Figure 19.48: Meridian Bioscience Revenue (by Segment), 2017-2019
  • Figure 19.49: Meridian Bioscience: Revenue (by Region), 2017-2019
  • Figure 19.50: Meridian Bioscience: R&D Expenditure, 2017-2019
  • Figure 19.51: Meridian Bioscience: SWOT Analysis
  • Figure 19.52: Macherey-Nagel GmbH & Co KG: Key Product Portfolio
  • Figure 19.53: Macherey-Nagel GmbH & Co KG: SWOT Analysis
  • Figure 19.54: New England Biolabs, Inc: Key Product Offerings
  • Figure 19.55: New England Biolabs, Inc.: SWOT Analysis
  • Figure 19.56: Norgen Biotek Corp.: Key Product Portfolio
  • Figure 19.57: Norgen Biotek Corp.: SWOT Analysis
  • Figure 19.58: Omega Bio-Tek: Key Product Portfolio
  • Figure 19.59: Omega Bio-Tek: SWOT Analysis
  • Figure 19.60: Orasure Technologies, Inc.: Key Product Portfolio
  • Figure 19.61: Orasure Technologies, Inc.: Overall Financials, 2016-2018
  • Figure 19.62: Orasure Technologies, Inc. Revenue (by Segment), 2016-2018
  • Figure 19.63: Orasure Technologies, Inc.: Revenue (by Region), 2016-2018
  • Figure 19.64: Orasure Technologies, Inc.: R&D Expenditure, 2016-2018
  • Figure 19.65: Orasure Technologies, Inc.: SWOT Analysis
  • Figure 19.66: PerkinElmer, Inc.: Key Product Portfolio
  • Figure 19.67: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
  • Figure 19.68: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 19.69: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
  • Figure 19.70: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
  • Figure 19.71: PerkinElmer, Inc.: SWOT Analysis
  • Figure 19.72: Promega Corporation: Key Product Portfolio
  • Figure 19.73: Promega Corporation: SWOT Analysis
  • Figure 19.74: QIAGEN N.V.: Key Product Offerings
  • Figure 19.75: QIAGEN N.V.: Overall Financials, 2016-2018
  • Figure 19.76: QIAGEN N.V.: Revenue (by Segment), $Million, 2016-2018
  • Figure 19.77: QIAGEN N.V.: Revenue (by Region), 2016-2018
  • Figure 19.78: QIAGEN N.V.: R&D Expenditure, 2016-2018
  • Figure 19.79: QIAGEN N.V.: SWOT Analysis
  • Figure 19.80: Sage Science, Inc.: Key Product Portfolio
  • Figure 19.81: Sage Science, Inc.: SWOT Analysis
  • Figure 19.82: Tecan Group: Key Product Portfolio
  • Figure 19.83: Tecan Group: Overall Financials, 2016-2018
  • Figure 19.84: Tecan Group Revenue (by Segment), 2016-2018
  • Figure 19.85: Tecan Group: Revenue (by Region), 2016-2018
  • Figure 19.86: Tecan Group: R&D Expenditure, 2016-2018
  • Figure 19.87: Tecan Group: SWOT Analysis
  • Figure 19.88: Thermo Fisher Scientific Inc.: Key product Offerings
  • Figure 19.89: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 19.90: Thermo Fisher Scientific Inc: Sales (by Segment), $Million, 2016-2018
  • Figure 19.91: Thermo Fisher Scientific Inc.: Sales (by Region), 2016-2018
  • Figure 19.92: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
  • Figure 19.93: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 19.94: Zymo Research: Key Product Portfolio
  • Figure 19.95: Zymo Research: SWOT Analysis